Skip to main content
Log in

Predictive value of HIV-1 RNA detection in plasma by branched DNA assay during long-term zidovudine therapy

  • Articles
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The predictive value of human immunodeficiency virus type 1 (HIV-1) RNA detection in plasma using branched DNA assay was studied in a subgroup of 36 asymptomatic HIV-1-infected patients enrolled in a multicenter, double-blind, randomized study. Patients were randomized to receive either zidovudine (AZT) 1 g/day or placebo and were monitored for a mean time of 61 months. HIV-1 RNA was detected in plasma using branched DNA assay at months 0, 6, 12, 24, and 36. HIV-1 RNA was detected at levels of ≥ 104 RNA eq/ml (eq/ml) in 8.3% of the patients at baseline, and this percentage increased during the first two years in the placebo group only. The detection rate of HIV-1 RNA at three years was 50% in both the AZT and the placebo groups. HIV-1 RNA levels ranged from 104 to 478 × 103 RNA eq/ml. HIV-1 RNA was detected at levels of > 104 eq/ml a mean time of 19±13 months before progression to AIDS in 76.5% of progressing patients. In a multivariate analysis including baseline CD4+ count, the initial randomization group, HIV-1 RNA detection in plasma, and detection of p24 antigenemia during the first three years of follow-up, the best independent predictors of progression to AIDS at five years and the best independent predictors of death at five years were HIV-1 RNA detection in plasma and p24 antigenemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schnittman SM, Greenhouse JJ, Psallidopoulos MC, Baseler M, Salzman NP, Fauci AS, Clifford Lane H: Increasing viral burden in CD4+ cells in HIV-1 reflects rapidly progressive immunosuppression and clinical disease. Annals of Internal Medicine 1990, 113: 438–443.

    PubMed  Google Scholar 

  2. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362: 359–362.

    PubMed  Google Scholar 

  3. Gupta P, Kingsley L, Armstrong J, Ding M, Cotrill M, Rinaldo C: Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 1993, 196: 586–595.

    PubMed  Google Scholar 

  4. Montoya JG, Wood R, Katzenstein D, Holodny M, Merigan T: Peripheral blood mononuclear cell human immunodeficiency virus type 1 proviral DNA quantification by polymerase chain reaction: relationship to immunodeficiency and drug effect. Journal of Clinical Microbiology 1993, 31: 2692–2696.

    PubMed  Google Scholar 

  5. Pantaleo G, Graziosi C, Desmarets JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362: 355–358.

    PubMed  Google Scholar 

  6. Ho DD, Moudgil T, Alam M: Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. New England Journal of Medicine 1989, 321: 1621–1625.

    PubMed  Google Scholar 

  7. Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L: Plasma viremia in human immunodeficiency virus infection. New England Journal of Medicine 1989, 321: 1626–1631.

    PubMed  Google Scholar 

  8. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S: Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. Journal of Clinical Microbiology 1994, 32: 292–300.

    PubMed  Google Scholar 

  9. Van Gemen B, Kievits T, Schukkink R, Van Strijp D, Malek LT, Sooknanan R, Huisman HG, Lens P: Quantitation of HIV-1 RNA in plasma using NASBATM during HIV-1 primary infection. Journal of Virological Methods 1993, 43: 177–188.

    PubMed  Google Scholar 

  10. Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong SJ, Stempien M, Hoo B, Besemer D, Yeghiazarian T, Irvine B, Kolberg J, Kokka R, Neuwald P, Urdea MS: Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995, 8: 446–454.

    PubMed  Google Scholar 

  11. Urdea MS, Wilber JC, Yeghiazarian T, Todd JA, Kern DG, Fong SJ, Besemer D, Hoo B, Sheridan PJ, Kokka R, Neuwald P, Pachl CA: Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay. AIDS 1993, 7, Supplement 2: 11–14.

    Google Scholar 

  12. Dewar RL, Highbarger HC, Sarmiento MD, Todd JA, Vasudevachari MB, Davey RT Jr, Kovacs JA, Salzman NP, Clifford Lane H, Urdea MS: Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. Journal of Infectious Diseases 1994, 170: 1172–1179.

    PubMed  Google Scholar 

  13. Todd J, Pachi C, White R, Yeghiazarian T, Johnson P, Taylor B, Holodniy M, Kern D, Hamren S, Chernoff D, Urdea M: Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995, 10, Supplement 2: 35–44.

    Google Scholar 

  14. Cao Y, Ho DD, Todd J, Kokka R, Urdea M, Lifson JD, Piatak M Jr, Chen S, Hahn BH, Saag MS, Shaw GM: Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Research and Human Retrovirus 1995, 11: 353–361.

    Google Scholar 

  15. Concorde Coordinating Committee: Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994, 343: 871–881.

    Google Scholar 

  16. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 1987, 36, Supplement 1S: 1–15.

    Google Scholar 

  17. Mellors JW, Lawrence AK, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Annals of Internal Medicine 1995, 122: 573–579.

    PubMed  Google Scholar 

  18. Choi S, Lagakos SW, Schooley RT, Volberding PA: CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection. Annals of Internal Medicine 1993, 118: 674–680.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cotte, L., Trabaud, M.A., Rougier, P. et al. Predictive value of HIV-1 RNA detection in plasma by branched DNA assay during long-term zidovudine therapy. Eur. J. Clin. Microbiol. Infect. Dis. 15, 639–645 (1996). https://doi.org/10.1007/BF01691149

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01691149

Keywords

Navigation